Segment and corporate information (Details) - EUR (€)
€ in Thousands |
3 Months Ended |
6 Months Ended |
|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
€ 4,317,259
|
€ 4,283,699
|
€ 8,463,653
|
€ 8,639,203
|
|
| Revenue from insurance contracts |
518,372
|
488,279
|
965,391
|
991,639
|
|
| Revenue from lease contracts |
24,935
|
19,735
|
43,669
|
42,325
|
|
| Revenue |
4,860,566
|
4,791,713
|
9,472,713
|
9,673,167
|
|
| Costs of revenue |
(3,550,584)
|
(3,577,352)
|
(6,983,239)
|
(7,274,828)
|
|
| Research and development |
(39,630)
|
(38,116)
|
(77,939)
|
(81,598)
|
|
| Operating income (loss) |
465,855
|
425,283
|
752,050
|
756,673
|
|
| Interest |
(82,856)
|
(74,729)
|
(161,535)
|
(155,466)
|
|
| Income before income taxes |
382,999
|
350,554
|
590,515
|
601,207
|
|
| Depreciation and amortization |
(357,159)
|
(362,031)
|
(711,060)
|
(744,628)
|
|
| Impairment loss |
(5,953)
|
(13,204)
|
(114,993)
|
(24,970)
|
|
| Income (loss) from equity method investees |
(41,256)
|
45,175
|
66
|
93,008
|
|
| Total assets |
31,293,240
|
31,291,184
|
31,293,240
|
31,291,184
|
€ 31,002,333
|
| thereof investment in equity method investees |
660,694
|
710,728
|
660,694
|
710,728
|
€ 663,652
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
350,246
|
286,994
|
668,064
|
604,702
|
|
| Healthcare services |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
3,252,174
|
3,225,352
|
6,396,681
|
6,501,665
|
|
| Revenue |
3,252,174
|
3,225,352
|
6,396,681
|
6,501,665
|
|
| Healthcare products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
1,065,085
|
1,058,347
|
2,066,972
|
2,137,538
|
|
| Revenue from lease contracts |
24,935
|
19,735
|
43,669
|
42,325
|
|
| Revenue |
1,090,020
|
1,078,082
|
2,110,641
|
2,179,863
|
|
| Total Segment |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
4,317,259
|
4,283,699
|
8,463,653
|
8,639,203
|
|
| Revenue from insurance contracts |
518,372
|
488,279
|
965,391
|
991,639
|
|
| Revenue from lease contracts |
24,935
|
19,735
|
43,669
|
42,325
|
|
| Revenue |
4,860,566
|
4,791,713
|
9,472,713
|
9,673,167
|
|
| Total Segment | Healthcare services |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
3,252,174
|
3,225,352
|
6,396,681
|
6,501,665
|
|
| Total Segment | Healthcare products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
1,065,085
|
1,058,347
|
2,066,972
|
2,137,538
|
|
| Care Delivery |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
3,340,048
|
3,262,807
|
6,512,737
|
6,590,551
|
|
| Revenue |
3,340,048
|
3,262,807
|
6,512,737
|
6,590,551
|
|
| Care Delivery | Healthcare services |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
3,234,409
|
3,207,936
|
6,335,565
|
6,458,118
|
|
| Care Delivery | Healthcare products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
105,639
|
54,871
|
177,172
|
132,433
|
|
| Value-Based Care |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
17,765
|
17,416
|
61,116
|
43,547
|
|
| Revenue from insurance contracts |
518,372
|
488,279
|
965,391
|
991,639
|
|
| Revenue |
536,137
|
505,695
|
1,026,507
|
1,035,186
|
|
| Value-Based Care | Healthcare services |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
17,765
|
17,416
|
61,116
|
43,547
|
|
| Care Enablement |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
959,446
|
1,003,476
|
1,889,800
|
2,005,105
|
|
| Revenue from lease contracts |
24,935
|
19,735
|
43,669
|
42,325
|
|
| Revenue |
984,381
|
1,023,211
|
1,933,469
|
2,047,430
|
|
| Care Enablement | Healthcare products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
959,446
|
1,003,476
|
1,889,800
|
2,005,105
|
|
| Care Enablement | Certain pharmaceutical products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue from contracts with customers |
|
18,309
|
|
38,885
|
|
| Operating Segments | Total Segment |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
5,385,511
|
5,234,220
|
10,468,442
|
10,577,471
|
|
| Costs of revenue |
(4,036,687)
|
(4,013,011)
|
(7,920,737)
|
(8,167,524)
|
|
| Research and development |
(39,709)
|
(38,116)
|
(77,939)
|
(81,598)
|
|
| Operating income (loss) |
550,893
|
426,583
|
898,312
|
844,130
|
|
| Depreciation and amortization |
(351,344)
|
(354,479)
|
(701,812)
|
(730,872)
|
|
| Impairment loss |
(5,843)
|
(13,204)
|
(79,663)
|
(24,970)
|
|
| Income (loss) from equity method investees |
(41,256)
|
45,175
|
66
|
93,008
|
|
| Total assets |
57,291,219
|
54,297,930
|
57,291,219
|
54,297,930
|
|
| thereof investment in equity method investees |
660,694
|
710,728
|
660,694
|
710,728
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
363,773
|
291,378
|
684,718
|
613,506
|
|
| Operating Segments | Care Delivery |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
3,478,314
|
3,380,682
|
6,771,882
|
6,827,510
|
|
| Costs of revenue |
(2,594,852)
|
(2,603,301)
|
(5,141,438)
|
(5,342,930)
|
|
| Operating income (loss) |
434,946
|
346,402
|
706,134
|
666,399
|
|
| Depreciation and amortization |
(230,694)
|
(243,716)
|
(463,131)
|
(504,322)
|
|
| Impairment loss |
(5,531)
|
(10,003)
|
(75,400)
|
(17,079)
|
|
| Income (loss) from equity method investees |
(41,256)
|
45,175
|
66
|
93,008
|
|
| Total assets |
42,076,323
|
39,706,254
|
42,076,323
|
39,706,254
|
|
| thereof investment in equity method investees |
660,694
|
710,728
|
660,694
|
710,728
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
251,534
|
177,749
|
454,200
|
387,485
|
|
| Operating Segments | Value-Based Care |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
536,137
|
505,695
|
1,026,507
|
1,035,186
|
|
| Costs of revenue |
(495,322)
|
(486,685)
|
(946,708)
|
(979,314)
|
|
| Operating income (loss) |
17,330
|
(8,842)
|
6,292
|
(5,593)
|
|
| Depreciation and amortization |
(197)
|
(1,435)
|
(855)
|
(2,676)
|
|
| Impairment loss |
|
82
|
|
(2,192)
|
|
| Total assets |
616,408
|
590,177
|
616,408
|
590,177
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
103
|
91
|
141
|
198
|
|
| Operating Segments | Care Enablement |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
1,371,060
|
1,347,843
|
2,670,053
|
2,714,775
|
|
| Costs of revenue |
(946,513)
|
(923,025)
|
(1,832,591)
|
(1,845,280)
|
|
| Research and development |
(39,709)
|
(38,116)
|
(77,939)
|
(81,598)
|
|
| Operating income (loss) |
98,617
|
89,023
|
185,886
|
183,324
|
|
| Depreciation and amortization |
(120,453)
|
(109,328)
|
(237,826)
|
(223,874)
|
|
| Impairment loss |
(312)
|
(3,283)
|
(4,263)
|
(5,699)
|
|
| Total assets |
14,598,488
|
14,001,499
|
14,598,488
|
14,001,499
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
112,136
|
113,538
|
230,377
|
225,823
|
|
| Operating Segments | Care Enablement | Certain pharmaceutical products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Costs of revenue |
|
(14,157)
|
|
(29,918)
|
|
| Operating income (loss) |
|
1,602
|
|
3,868
|
|
| Operating Segments | Corporate |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Costs of revenue |
328
|
1,534
|
2,390
|
2,090
|
|
| Research and development |
79
|
|
|
|
|
| Operating income (loss) |
(45,868)
|
7,082
|
(85,641)
|
(73,758)
|
|
| Depreciation and amortization |
(15,692)
|
(16,958)
|
(29,175)
|
(33,998)
|
|
| Impairment loss |
(110)
|
|
(35,330)
|
|
|
| Total assets |
12,116,023
|
11,396,571
|
12,116,023
|
11,396,571
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
34,994
|
6,558
|
59,365
|
11,975
|
|
| Inter-segment |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
(524,945)
|
(442,507)
|
(995,729)
|
(904,304)
|
|
| Costs of revenue |
485,775
|
434,125
|
935,108
|
890,606
|
|
| Operating income (loss) |
(39,170)
|
(8,382)
|
(60,621)
|
(13,699)
|
|
| Depreciation and amortization |
9,877
|
9,406
|
19,927
|
20,242
|
|
| Total assets |
(38,114,002)
|
(34,403,317)
|
(38,114,002)
|
(34,403,317)
|
|
| Additions of property, plant and equipment, intangible assets and right-of-use assets |
(48,521)
|
(10,942)
|
(76,019)
|
(20,779)
|
|
| Inter-segment | Total Segment |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
(524,945)
|
(442,507)
|
(995,729)
|
(904,304)
|
|
| Inter-segment | Care Delivery |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
(138,266)
|
(117,875)
|
(259,145)
|
(236,959)
|
|
| Inter-segment | Care Enablement |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
€ (386,679)
|
(324,632)
|
€ (736,584)
|
(667,345)
|
|
| Inter-segment | Care Enablement | Certain pharmaceutical products |
|
|
|
|
|
| Segment and corporate information |
|
|
|
|
|
| Revenue |
|
€ (1,296)
|
|
€ (2,592)
|
|